<?xml version="1.0" encoding="UTF-8"?>
<p>EV-A71 strain 41 (5865/SIN/000009, GenBank accession no. AF316321; subgenogroup B4) was used for construction of infectious clones using a DNA-launched strategy as reported previously [
 <xref rid="ppat.1007863.ref086" ref-type="bibr">86</xref>]. Unlike its original sequence, this lab strain had been propagated in tissue culture previously and had acquired a VP1-E145Q mutation. We have denoted this strain as KEQ.
</p>
